Geoffrey Guy
Geoffrey Guy | |
---|---|
Born | 1954 (age 69–70) Stanmore , Middlesex, England |
Nationality | British |
Education | |
Known for | Co-founder GW Pharmaceuticals |
Medical career | |
Research | |
Notable works | The Medicinal Uses of Cannabis and Cannabinoids (2004) |
Geoffrey William Guy (born 1954) is a British pharmacologist, physician, businessman and academic, who co-founded GW Pharmaceuticals and has developed treatments using compounds found in cannabis, which are the first cannabis-based medicines approved by and available on the British National Health Service (NHS).
In the 1980s and 1990s he was successful in the opiate painkiller business, and held appointments at the Laboratoires Pierre Fabre and the Napp laboratories. He was a member of the editorial board of the Journal of Cannabis Therapeutics, and has authored, contributed to and edited over 200 clinical studies and several books including The Medicinal Uses of Cannabis and Cannabinoids (2004).
Early life and education
Geoffrey Guy was born in 1954 in
Following A levels at a sixth form college near
Career
Guy began his career in the pharmaceutics industry in 1980 and became successful in the opiate painkiller business.[3][4] From 1981 to 1983, he served as international clinical research co-ordinator at Laboratoires Pierre Fabre,[2] where his research involved seeking out active ingredients in plants for the purpose of developing medicines.[3] It led to the concept that there could be ingredients in the same plant that acted in opposition to each other.[3]
From 1983 to 1985 he was director of clinical development at the
In 1998, he co-founded
In early 2021, it was announced that GW would be acquired by Dublin-based Jazz Pharmaceuticals for US$7.2 billion.[17] The deal was completed in May 2021,[18] at which time Guy resigned from the chairmanship of the company.[19]
Writing
Guy was a member of the editorial board of the
In 2004 he was co-editor of
Awards and honours
In 2011 Guy was recipient of the Deloitte Director of the Year Award in Pharmaceuticals and Healthcare.[20] In the same year he was appointed as visiting professor in the School of Science and Medicine at the University of Buckingham.[22] In 2016, he was awarded the honorary degree of Doctor of Science from the University of Reading and was also appointed visiting professor at the University of Westminster.[20][22]
Other roles
Guy is on the board of trustees for Leweston School.[23]
Selected publications
Books
- Guy, Geoffrey William; Whittle, Brian Anthony; Robson, Philip (2004). The Medicinal Uses of Cannabis and Cannabinoids. ISBN 978-0-85369-517-2.
- Guy, Geoffrey (2021). A Worthwhile Medicine: How the World's First Cannabis-Based Medication Was Approved. London: ISBN 978-1-78816-763-5.
Articles
- Whittle, Brian A.; Guy, Geoffrey W.; Robson, Philip (1 June 2001). "Prospects for New Cannabis-Based Prescription Medicines". Journal of Cannabis Therapeutics. 1 (3–4): 183–205. ISSN 1529-9775. (Co-authored)
- Russo, Ethan; Guy, Geoffrey W. (2006). "A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol". Medical Hypotheses. 66 (2): 234–246. PMID 16209908. (Co-authored)
- Russo, Ethan B.; Guy, Geoffrey W.; Robson, Philip J. (2007). "Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex®, a Cannabis-Based Medicine". Chemistry & Biodiversity. 4 (8): 1729–1743. S2CID 38580755. (Co-authored)
- Nunn, Alistair V.W.; Guy, Geoffrey W.; Bell, Jimmy D. (15 August 2016). "The quantum mitochondrion and optimal health". Biochemical Society Transactions. 44 (4): 1101–1110. PMID 27528758. (Co-authored)
References
- ^ ISBN 978-1-78816-763-5.
- ^ a b c d e f g h Crowther S. M, Reynolds L. A, Tansey E. M. (eds) (2010) The medicalization of cannabis, Wellcome Witnesses to Twentieth Century Medicine, vol. 40. London: The Wellcome Trust Centre for the History of Medicine at UCL. ISBN 978 085484 129 5. p.91
- ^ a b c d e Crowther S. M, Reynolds L. A, Tansey E. M. (eds) (2010) The medicalization of cannabis, Wellcome Witnesses to Twentieth Century Medicine, vol. 40. London: The Wellcome Trust Centre for the History of Medicine at UCL. ISBN 978 085484 129 5. pp.30–40
- ISBN 978-0-19-928342-2.
- ^ a b GW Pharmaceuticals plc. p. 10.
- ^ ISBN 978-1-119-69101-3.
- ^ ISBN 0-19-513123-1.
- ^ "The Medicalization of Cannabis | The History of Modern Biomedicine". www.histmodbiomed.org. Retrieved 24 July 2021.
- ^ a b Scialom, Mike (29 April 2021). "GW Pharmaceuticals wins Queen's Award as cannabinoid treatments proliferate". Cambridge Independent. Retrieved 17 August 2021.
- ^ a b Elvidge, Suzanne (7 October 2010). "The Challenges Of Bringing A Cannabis-Based Drug To Market". www.pharmaceuticalonline.com. Archived from the original on 3 August 2021. Retrieved 3 August 2021.
- ^ "Geoffrey Guy, Chairman, GW Pharma". PharmaBoardroom. 4 September 2018. Archived from the original on 18 July 2021. Retrieved 18 July 2021.
- ^ ISBN 978-0-19-966268-5.
- ^ "FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy". FDA. 27 March 2020. Archived from the original on 11 August 2021. Retrieved 11 August 2021.
- ^ "EPIDIOLEX® (cannabidiol) Oral Solution – the First FDA-approved Plant-derived Cannabinoid Medicine – Now Available by Prescription in the U.S. | GW Pharmaceuticals". ir.gwpharm.com. 1 November 2018. Archived from the original on 2 December 2020. Retrieved 11 August 2021.
- S2CID 205095819.
- ^ "Cannabis-based medicines: Two drugs approved for NHS". BBC News. 11 November 2019. Archived from the original on 11 August 2021. Retrieved 11 August 2021.
- ^ Banerjee, Ankur; Khan, Shariq; Rebecca, Spalding (3 February 2021). "Jazz Pharma to buy GW Pharma for $7.2 billion, adding cannabis-based drug to portfolio". Reuters. Archived from the original on 30 March 2021. Retrieved 6 August 2021.
- ^ "Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc | Jazz Pharmaceuticals plc". investor.jazzpharma.com. Archived from the original on 6 August 2021. Retrieved 6 August 2021.
- ^ "GW Pharmaceuticals Limited". find-and-update.company-information.service.gov.uk. Archived from the original on 30 July 2021. Retrieved 6 August 2021.
- ^ a b c "University of Reading". University of Reading. Archived from the original on 7 September 2020. Retrieved 19 July 2021.
- ^ Whipple-Guthrie, Ellen. "The Medicinal of Cannabis and Cannabinoids". mscare.org. Archived from the original on 11 August 2021. Retrieved 19 July 2021.
- ^ a b "Geoffrey Guy". ir.gwpharm.com. Archived from the original on 11 August 2021. Retrieved 3 August 2021.
- ^ "Leweston School Trust". scoriff.co.uk. Retrieved 19 July 2021.
Further reading
- Guy, Geoffrey W.; Stott, Colin G. (2006). "The development of Sativex - a natural cannabis based medicine". In Mechoulam, Raphael (ed.). Cannabinoids as Therapeutics. Springer. p. 231. ISBN 3-7643-7055-6.
External links
- "The Guy Foundation". The Guy Foundation Family Trust.